Hangzhou Yuding Biotechnology Co.
Latest round
- Series A
Last raised
- Jan 2022
Total raised
- Undisclosed
Investors
- 1
About Hangzhou Yuding Biotechnology Co.
, Ltd. is an innovative in vitro diagnostic reagent research and development and production enterprise that focuses on urological oncology field. The company has international good manufacturing practice (GMP) standard production base and research and development center. The company also was certificated as National High-tech Enterprise. Dr. Jiaoti Huang, the founder of the company, works as director of department of Pathology, Duke University. The development and clinical validation of urological tumor early diagnostic products of the company have been finished. The company also has cooperation with West China Hospital, Sichuan University, The First Affiliated Hospital, College of Medicine, Zhejiang University, Nanjing Gulou Hospital and other hospitals. The company plans to focus on clinical trials and registration filings for Class III medical device products, as well as the development of other urological oncology pipeline products and the optimization and upgrading of its core technology platform.
Who invested in Hangzhou Yuding Biotechnology Co.
1 investor across 1 round
See all investors in Hangzhou Yuding Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 28, 2022
Amount
Undisclosed
Investors
Questions about Hangzhou Yuding Biotechnology Co.
Who invested in Hangzhou Yuding Biotechnology Co.?
Hangzhou Yuding Biotechnology Co. has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hangzhou Yuding Biotechnology Co. raised?
Hangzhou Yuding Biotechnology Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Hangzhou Yuding Biotechnology Co. last raise money?
Hangzhou Yuding Biotechnology Co.'s most recent round on record is a Series A, in Jan 2022.
What does Hangzhou Yuding Biotechnology Co. do?
Hangzhou Yuding Biotechnology Co. is a biotechnology company.
Where is Hangzhou Yuding Biotechnology Co. headquartered?
Hangzhou Yuding Biotechnology Co. is headquartered in Hangzhou, China.
Which VCs invest in companies like Hangzhou Yuding Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Hangzhou Yuding Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Hangzhou Yuding Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.